Search - tctmd.com

Displaying 101 - 118 of 118

Sort: Relevancy | Date

News Conference News ESC 2014

Mitral Regurgitation Associated with Decreased Survival in TAVR Patients

Yael L. Maxwell

September 03, 2014

News Daily News

Some Long-term Drop-Off in Favorable Outcomes Seen in Early CoreValve Series

July 03, 2014

News Daily News

Se Observa Cierto Empeoramiento a Largo Plazo en los Resultados Favorables de una Serie Inicial de CoreValve

July 03, 2014

News Daily News

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

March 20, 2014

News Daily News

CoreValve Reduce la Mortalidad al cabo de 1 Año en Pacientes de Riesgo Quirúrgico Extremo

March 20, 2014

News Daily News

Study Questions Ability of TAVR to Improve Psychological, General Health

L.A. McKeown

March 13, 2014

News Industry News

Medtronic CoreValve® System Obtains Early FDA Approval

January 16, 2014

News Daily News

La Fiebre tras la TAVR es Común aunque los Antibióticos No suelen ser Necesarios

L.A. McKeown

January 15, 2014

News Daily News

Fever After TAVR Common, but Antibiotics Rarely Needed

L.A. McKeown

January 15, 2014

News Daily News

La Anemia, Presente en Más de la Mitad de los Pacientes TAVR, condiciona una Mortalidad a Largo Plazo

Jason Kahn

January 01, 2014

News Daily News

Anemia Present in More than Half of TAVR Patients, Raises Long-term Mortality

Jason Kahn

January 01, 2014

Presentation TCT 2013

The Valve Medical TAVR System (Israel)

Presenter: Martin Leon

October 28, 2013

Presentation TVT 2013

The Valve Medical TAVR System (Israel)

Presenter: Martin Leon

June 13, 2013

News Conference News EuroPCR 2013

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Jason Kahn

May 24, 2013

News Daily News

Post-TAVR Hypertension Common, Predicts Better Outcomes

May 03, 2013

News Daily News

La Hipertensión Post-TAVR es Frecuente y Predice Mejores Resultados

May 03, 2013

News Conference News ACC 2013

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

L.A. McKeown

March 09, 2013

Presentation TVT 2012

Israeli Perspectives on Defining the High-Risk Patient Suitable for TAVR

Presenter: Ran Kornowski

June 05, 2012

Advertisement

Mitral Regurgitation Associated with Decreased Survival in TAVR Patients

Some Long-term Drop-Off in Favorable Outcomes Seen in Early CoreValve Series

Se Observa Cierto Empeoramiento a Largo Plazo en los Resultados Favorables de una Serie Inicial de CoreValve

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

CoreValve Reduce la Mortalidad al cabo de 1 Año en Pacientes de Riesgo Quirúrgico Extremo

Study Questions Ability of TAVR to Improve Psychological, General Health

Medtronic CoreValve® System Obtains Early FDA Approval

La Fiebre tras la TAVR es Común aunque los Antibióticos No suelen ser Necesarios

Fever After TAVR Common, but Antibiotics Rarely Needed

La Anemia, Presente en Más de la Mitad de los Pacientes TAVR, condiciona una Mortalidad a Largo Plazo

Anemia Present in More than Half of TAVR Patients, Raises Long-term Mortality

The Valve Medical TAVR System (Israel)

The Valve Medical TAVR System (Israel)

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Post-TAVR Hypertension Common, Predicts Better Outcomes

La Hipertensión Post-TAVR es Frecuente y Predice Mejores Resultados

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

Israeli Perspectives on Defining the High-Risk Patient Suitable for TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content